Chengyi Biotechnology

BiotechnologySeries BShanghai, Chinaeccogene.com

Latest round

Series B

Last raised

Jun 2023

Total raised

$55M

Investors

13

About Chengyi Biotechnology

Based in Shanghai, China and established in 2018, Chengyi Biotechnology is a pharmaceutical company that focuses on developing innovative small-molecule drugs. Jingye Zhou, the founder and CEO of the company, used to be the head of the chemical department of Lilly China R&D Center. The company's main products include low-dose small molecule GLP-1 receptor agonists, THR-ß full agonists and SSAO/VAP-1 inhibitors, etc. Its products are used in metabolic and immune-related diseases.

Who invested in Chengyi Biotechnology

13 investors across 4 rounds

See all investors in Chengyi Biotechnology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 12, 2023

    Amount

    $25M

    Investors

    Locked

  2. Series C

    Mar 16, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Dec 22, 2020

    Amount

    $15M

    Investors

    Locked

  4. Series A

    Sep 6, 2018

    Amount

    $15M

    Investors

    Locked

Questions about Chengyi Biotechnology

Who invested in Chengyi Biotechnology?

Chengyi Biotechnology has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Chengyi Biotechnology raised?

Chengyi Biotechnology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Chengyi Biotechnology last raise money?

Chengyi Biotechnology's most recent round on record is a Series B, in Jun 2023.

What does Chengyi Biotechnology do?

Based in Shanghai, China and established in 2018, Chengyi Biotechnology is a pharmaceutical company that focuses on developing innovative small-molecule drugs.

Where is Chengyi Biotechnology headquartered?

Chengyi Biotechnology is headquartered in Shanghai, China.

Which VCs invest in companies like Chengyi Biotechnology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Chengyi Biotechnology's stage. Their profiles are linked below.

Raising like Chengyi Biotechnology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.